Going Concern (removed) — Auditor removed substantial-doubt language after company raised $74M and extended cash runway beyond 12 months.
Auditor Change (new) — Auditor changed from Moss Adams to Baker Tilly, both claiming service since 2018; no explanation provided for transition.

NASDAQ: SLS SELLAS Life Sciences Group, Inc. 10-K

SELLAS exits going concern, raises $74M, advances SLS009 to first-line AML trial

Filed March 19, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 20, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SLS commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 4, 2026 6:50 AM